Clinical Trial Update: Repurposing Ivermectin for PKDL Treatment [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study evaluated repurposing ivermectin for Post-kala-azar Dermal Leishmaniasis, and the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-kala-azar Dermal Leishmaniasis

Drugs mentioned

• IVERMECTIN (Ivermectin)

Snippet

Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh | Conditions: Post-kala-azar Dermal Leishmaniasis | EARLY_Phase 1 | Status: COMPLETED